This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Skystar Bio-Pharmaceutical Co (SKBI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 8.14M 11.32M 7.05M 5.89M
Receivables 11.01M 11.09M 4.86M 14.58M
Inventories 25.90M 22.96M 14.85M 7.20M
Other Current Assets 2.13M 2.84M 0.00 0.00
Total Current Assets 88.62M 71.65M 58.90M 44.74M
Property, Plant & Equipment, Gross 44.03M 42.70M 41.29M 26.81M
Accumulated Depreciation & Depletion 6.48M 5.14M 4.07M 2.61M
Property, Plant & Equipment, Net 37.55M 37.56M 37.22M 24.20M
Intangibles 5.24M 5.32M 5.67M 6.04M
Other Non-Current Assets 4.82M 1.23M 2.08M 6.26M
Total Non-Current Assets 47.61M 44.11M 44.97M 36.51M
Liabilities & Shareholder Equity
Total Assets 136.22M 115.76M 103.88M 81.25M
Accounts Payable 13.01M 10.81M 6.38M 3.58M
Short Term Debt 10.64M 4.44M 7.37M 3.03M
Other Current Liabilities 1.32M 1.95M 1.59M 749.84K
Total Current Liabilities 24.97M 17.21M 15.34M 7.35M
Long Term Debt 0.00 1.27M 0.00 0.00
Deferred Income Taxes 802.13K 1.06M 393.50K 986.05K
Other Non-Current Liabilities 62.44K 5.60K 43.40K 1.42M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 864.57K 2.34M 436.90K 2.41M
Total Liabilities 25.83M 19.54M 15.77M 9.76M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 110.39M 96.21M 88.10M 71.49M
Common Par 7.60K 7.60K 7.16K 7.16K
Additional Paid In Capital 37.63M 37.02M 35.78M 35.78M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 54.99M 44.52M 38.49M 24.85M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 17.76M 14.67M 13.82M 10.85M
Total Capitalization 110.39M 97.48M 88.10M 71.49M
Total Equity 110.39M 96.21M 88.10M 71.49M
Total Liabilities & Stock Equity 136.22M 115.76M 103.88M 81.25M
Total Common Shares Outstanding 7.60M 7.60M 7.16M 7.16M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 7.65M 7.47M 7.18M 7.11M
Diluted Weighted Shares Outstanding 7.66M 7.47M 7.18M 7.14M
Number of Employees 318 317 320 172
Number of Part-Time Employees 0 0 0 41
SKBI News

SKBI Skystar Bio-Pharmaceutical Co

Analysts Ratings for SKBI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SKBI ANALYST REPORT

Brokerage Partners

SKBI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs